Cannabinoid CB2 receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux

European Journal of Pharmacology

Volumn 573, Issue 1-3, 2007, Pages 206-213

  Cui, Yong Yao ^a,b   D'Agostino, Bruno ^c   Risse, Paul André ^a   Marrocco, Guiseppina ^c   Naline, Emmanuel ^a   Zhang, Yong ^b   Chen, Hong Zhuan ^b   Finance, Olivier ^d   Rinaldi Carmona, Murielle ^d   Rossi, Francesco ^c   Advenier, Charles ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d SANOFI   (France)

Author keywords

(Guinea pig); Bronchoconstriction; Cannabinoids; Microvascular leakage

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 2 RECEPTOR; RIMONABANT; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EDEMA; EXTRAVASATION; GASTROESOPHAGEAL REFLUX; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE;

AIRWAY OBSTRUCTION; ANIMALS; BENZOXAZINES; BORNANES; BRONCHI; BRONCHOCONSTRICTION; CANNABINOIDS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGUS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GASTROESOPHAGEAL REFLUX; GUINEA PIGS; HYDROCHLORIC ACID; MALE; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PULMONARY EDEMA; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RESPIRATORY FUNCTION TESTS; TRACHEA;

EID: 34648852404     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.06.040     Document Type: Article

References (49)

1. Advenier C., D'Agostino B., Cui Y.Y., Eutamene H., Rouget C., Bardou M., and Bueno L. Animal models for investigating gastroesophageal reflux disease-induced asthma. In: Dal Negro R.W., Geppetti P., and Morice A.H. (Eds). Experimental and clinical pharmacology of gastroesophageal reflux-induced asthma (2002), Pacini Editore, Pisa 51-54
2. Akerman S., Holland P.R., and Goadsby P.J. Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. J. Pharmacol. Exp.Ther. 320 (2007) 64-71
3. Berdyshev E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 108 (2000) 169-190
4. Berdyshev E.V., Boichot E., Germain N., Allain N., Anger J.P., and Lagente V. Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur. J. Pharmacol. 330 (1997) 231-240
5. Calignano A., Katona I., Desarnaud F., Giuffrida A., La Rana G., Mackie K., Freund T.F., and Piomelli D. Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 408 (2000) 96-101
6. Conti S., Costa B., Colleoni M., Parolaro D., and Giagnoni G. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br. J. Pharmacol. 135 (2002) 181-187
7. Croci T., Manara L., Aureggi G., Guagnini F., Rinaldi-Carmona M., Maffrand J.P., Le Fur G., Mukenge S., and Ferla G. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br. J. Pharmacol. 125 (1998) 1393-1395
8. D'Agostino B., Marrocco G., De Nardo M., Calo G., Guerrini R., Gallelli L., Advenier C., and Rossi F. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux. Br. J. Pharmacol. 144 (2005) 813-820
9. Daoui S., D'Agostino B., Gallelli L., Emonds-Alt X., Rossi F., and Advenier C. Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation. Eur. Respir. J. 20 (2002) 268-273
10. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., and Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34 (1998) 605-613
11. de Vries A., van Rijnsoever C., Engels F., Henricks P.A., and Nijkamp F.P. The role of sensory nerve endings in nerve growth factor-induced airway hyperresponsiveness to histamine in guinea-pigs. Br. J. Pharmacol. 134 (2001) 771-776
12. Elmes S.J., Jhaveri M.D., Smart D., Kendall D.A., and Chapman V. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur. J. Neurosci. 20 (2004) 2311-2320
13. Gallelli L., D'Agostino B., Marrocco G., De Rosa G., Filipelli W., Rossi F., and Advenier C. Role of tachikinins in the bronchoconstriction induced by HCl intraesophageal instillation in the rabbit. Life Sci. 72 (2003) 1135-1142
14. Gallily R., Yamin A., Waksmann Y., Ovadia H., Weidenfeld J., Bar-Joseph A., Biegon A., Mechoulam R., and Shohami E. Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid. J. Pharmacol. Exp. Ther. 283 (1997) 918-924
15. Germain N., Boichot E., Advenier C., Berdyshev E.V., and Lagente V. Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells. Int. Immunopharmacol. 4 (2002) 537-543
16. Hamamoto J., Kohrogi H., Kawano O., Iwagoe H., Fujii K., Hirata N., and Ando M. Esophageal stimulation by hydrochloric acid causes neurogenic inflammation in the airways in guinea pigs. J. Appl. Physiol. 82 (1997) 738-745
17. Hanus L., Breuer A., Tchilibon S., Shiloah S., Goldenberg D., Horowitz M., Pertwee R.G., Ross R.A., Mechoulam R., and Fride E. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. U S A. 96 (1999) 14228-14233
18. Harding S.M., and Sontag S.J. Asthma and gastroesophageal reflux. Am. J. Gastroenterol. 95 (2000) S23-S32
19. Hervé P., Denjean A., Jian R., Simonneau G., and Duroux P. Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am. Rev. Respir. Dis. 134 (1986) 986-989
20. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., and Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54 (2002) 161-202
21. 8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg. Med. Chem. 7 (1999) 2905-2914
22. Jonsson K.O., Persson E., and Fowler C.J. The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro. Life Sci. 78 (2006) 598-606
23. Kagaya M., Lamb J., Robbins J., Page C.P., and Spina D. Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br. J. Pharmacol. 137 (2002) 39-48
24. Leggett J.J., Johnston B.T., Mills M., Gamble J., and Heaney L.G. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest 127 (2005) 1227-1231
25. Lilly C.M., Hall A.E., Rodger I.W., Kobzik L., Haley K.J., and Drazen J.M. Substance P-induced histamine release in tracheally perfused guinea pig lungs. J. Appl. Physiol. 78 (1995) 1234-1241
26. Mansfield L.E., Hameister H.H., Spaulding H.S., Smith N.J., and Glab N. The role of the vague nerve in airway narrowing caused by intraesophageal hydrochloric acid provocation and esophageal distention. Ann. Allergy 47 (1981) 431-434
27. Mathison R., Ho W., Pittman Q.J., Davison J.S., and Sharkey K.A. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. Br. J. Pharmacol. 142 (2004) 1247-1254
28. Matsuda L.A., Bonner T.I., and Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 327 (1993) 535-550
29. Mazzari S., Cannela R., Petrelli L., Marcolongo G., and Leon A. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol. 300 (1996) 227-236
30. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
31. Nackley A.G., Zvonok A.M., Makriyannis A., and Hohmann A.G. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. J. Neurophysiol. 92 (2004) 3562-3574
32. Nieri P., Martinotti E., Testai L., Adinolfi B., Calderone V., and Breschi M.C. R(+)-methanandamide inhibits tracheal responses to endogenously released acetylcholine via capsazepine-sensitive receptors. Eur. J. Pharmacol. 459 (2003) 75-81
33. Patel H.J., Birrell M.A., Crispino N., Hele D.J., Venkatesan P., Barnes P.J., Yacoub M.H., and Belvisi M.G. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br. J. Pharmacol. 140 (2003) 261-268
34. Porter A.C., and Felder C.C. The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol. Ther. 90 (2001) 45-60
35. Quartilho A., Mata H.P., Ibrahim M.M., Vanderah T.W., Porreca F., Makriyannis A., and Malan Jr. T.P. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99 (2003) 955-960
36. Ralevic V. Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur. J. Pharmacol. 472 (2003) 1-21
37. Ravinet-Trillou C., Arnone M., Delgorge C., Gonalons N., Keane P., Maffrand J.P., and Soubrie P. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol., Regul. Integr. Comp. Physiol. 284 (2003) R345-R353
38. Ricciardolo F.L. Mechanisms of citric acid-induced bronchoconstriction. Am. J. Med. 111 Suppl 8A (2001) 18S-24S
39. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrié P., Brelière J.C., and Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350 (1994) 240-244
40. Rinaldi-Carmona M., Barth F., Millan J., Derocq J.M., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Breliere J.C., and Le Fur G.L. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol. Exp. Ther. 284 (1998) 644-650
41. Rogers D.F., Belvisi M.G., Aursudkij B., Evans T.W., and Barnes P.J. Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs. Br. J. Pharmacol. 95 (1988) 1109-1116
42. Rouget C., Cui Y.Y., D'Agostino B., Faisy C., Naline E., Bardou M., and Advenier C. Nociceptin inhibits airway microvascular leakage induced by HCl intra-oesophageal instillation. Br. J. Pharmacol 141 (2004) 1077-1083
43. Tucker R.C., Kagaya M., Page C.P., and Spina D. The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. Br. J. Pharmacol. 132 (2001) 113-1127
44. Tuchman D.N., Boyle J.T., Pack A.I., Scwartz J., Kokonos M., Spitzer A.R., and Cohen S. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 87 (1984) 872-881
45. Valenzano K.J., Tafesse L., Lee G., Harrison J.E., Boulet J.M., Gottshall S.L., Mark L., Pearson M.S., Miller W., Shan S., Rabadi L., Rotshteyn Y., Chaffer S.M., Turchin P.I., Elsemore D.A., Toth M., Koetzner L., and Whiteside G.T. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Neuropharmacology 48 (2005) 658-672
46. Vannacci A., Giannini L., Passani M.B., Di Felice A., Pierpaoli S., Zagli G., Fantappie O., Mazzanti R., Masini E., and Mannaioni P.F. The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids. J. Pharmacol. Exp. Ther. 311 (2004) 256-264
47. Walter L., and Stella N. Cannabinoids and neuroinflammation. Br. J. Pharmacol. 14 (2004) 775-785
48. Yoshihara S., Morimoto H., Yamada Y., Abe T., and Arisaka O. Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways. Am. J. Respir. Crit. Care Med. 170 (2004) 941-946
49. Yoshihara S., Morimoto H., Ohori M., Yamada Y., Abe T., and Arisaka O. The cannabinoid receptor agonist WIN 55,212-2 inhibits neurogenic inflammations in airway tissues. J. Pharmacol. Sci. 98 (2005) 77-82